Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 178-184 , 8 October 2010

Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis

  • K.H. Chan

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Neuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Research Center of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Corresponding Author InformationCorresponding author. Department of Medicine, 4/F Professorial Block, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong. Tel.: +852 2855 3315; fax: +852 507 2974 1171.
    • ,
  • J.S.C. Kwan

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Neuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • P.W.L. Ho

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Research Center of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • S.L. Ho

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • Research Center of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • W.H. Chui

      Affiliations

    • University Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • A.C.Y. Chu

      Affiliations

    • University Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • J.W.M. Ho

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • W.Y. Zhang

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong
    • ,
  • M.H.W. Kung

      Affiliations

    • University Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong

Received 16 April 2010 ,Revised 17 May 2010 ,Accepted 19 July 2010.

References 

  1. Ami-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003;4:991–1001
  2. Ananth J, Davies R, Kerner B. Psychosis associated with thymoma. J. Nerv. Ment. Dis. 1984;172:556–558
  3. Antoine JC, Camdessanche JP, Absi L, Lassabliere F, Feasson L. Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology. 2004;62:978–980
  4. Auguste KI, Jin S, Uchida K, et al. Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J. 2007;21:108–116
  5. Bichuetti DB, de Barros TM, Oliveira EML, et al. Demyelinating disease in patients with myasthenia gravis. Arq. Neuropsiquiatr. 2008;66:5–7
  6. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009;66:630–643
  7. Chan KH, Lachance DH, Harper CM, Lennon VA. Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve. 2007;36:651–658
  8. Chan KH, Pittock SJ, Lennon VA. Coexisiting autoimmune channelopathies: neuromyelitis optica with myasthenia gravis. Neurology. 2008;70:A236;(Abstract)
  9. Chan KH, Ramsden DB, Yu YL, et al. NMO-IgG in idiopathic inflammatory demyelinating disorders among Hong Kong Chinese. Eur. J. Neurol. 2009;16:310–316
  10. Cheuk W, Tsang WY, Chan JK. Microthymoma: definition of the entity and distinction from nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma). Am. J. Surg. Pathol. 2005;29(3):415–419
  11. Cree BAC, Goodin DS, Hauser SL. Neuromyelitis optica. Semin. Neurol. 2002;22:105–122
  12. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64:1270–1272
  13. de Seze J, et al. Devic's neuromyelitis: clinical, laboratory, MRI and outcome profile. J. Neurol. Sci. 2002;197:57–61
  14. Devic E. Myelite subaigue compliquee de nevrite optique. Bull. Med. (Paris). 1894;8:1033–1034
  15. Evoli A, MMinicuci GM, Vitaliani R, Battaglia A, Marca GD, Lauriola L, et al. Paraneoplastic diseases associated with thymoma. J. Neurol. 2007;254:756–762
  16. Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS. Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J. Cell Sci. 1995;108:2993–3002
  17. Furukawa Y, Yoshikawa H, Yachie A, Yamada M. Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur. J. Neurol. 2006;13:655–658
  18. Gerli R, Paganelli R, Cossarizza , et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J. Allergy Clin. Immunol. 1999;103:865–872
  19. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J. Neurol. 2004;251:47–52
  20. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:1–11
  21. Hiroaki Y, Tani K, Kamegawa A, et al. Implications of the aquaporin-4 structure on array formation and cell adhesion. J. Mol. Biol. 2006;355:628–639
  22. Hu J, Verkman AS. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J. 2006;20:1892–1894
  23. Jablonski EM, Webb AN, McConnell AM, Riley MC, Hughes FM. Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease. Am. J. Physiol. Cell Physiol. 2004;286:C975–C985
  24. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, et al. Treatment of neuromyelitis optica with rituximab. Retrospective analysis of 25 patients. Arch. Neurol. 2008;65(11):1443–1448
  25. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68:1076–1077
  26. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc. Natl. Acad. Sci. USA. 1994;91:13052–13056
  27. Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport. 2009;20:508–512
  28. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 2009;386:623–627
  29. Kister I, Gulati S, Boz C, et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch. Neurol. 2006;63:851–856
  30. Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J. Neurol. Neurosurg. Psychiatry. 1998;65:857–862
  31. Lennon VA. Serological profile of myasthenia gravis and distinction from the Lambert–Eaton myasthenic syndrome. Neurology. 1997;48(Supp 5):S23–S27
  32. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica. Lancet. 2004;364:2106–2112
  33. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to aquaporin-4 water channel. J. Exp. Med. 2005;202:473–477
  34. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450–1461
  35. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51:1219–1220
  36. McCoy E, Sontheimer H. Expression and function of water channels (aquaporins) in migrating malignant astrocytes. Glia. 2007;55(10):1034–1043
  37. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009;39(1):87–90
  38. Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 active in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J. Exp. Med. 2006;209:269–275
  39. Mori T, Nomori H, Ikeda K, Kobayashi H, Iwatani K, Yoshioka M, et al. Microscopic-sized “microthymoma” in patients with myasthenia gravis. Chest. 2007;131(3):847–849
  40. Mueller S, Dubal DB, Josephson SA. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat. Clin. Pract. Neurol. 2008;4:284–288
  41. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatry. 2006;77:1073–1075
  42. Neely JD, Christensen BM, Nielsen S, Agre P. Heterotetrameric composition of aquaporin-4 water channels. Biochemistry. 1999;38:11156–11163
  43. Ng WH, Hy JW, Tan WL, Liew D, Lim T, et al. Aquaporin-4 expression is increased in edematous meningiomas. J. Clin. Neurosci. 2009;16:441–443
  44. Nicchia GP, Nico B, Camassa LMA, et al. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience. 2004;129:935–945
  45. Nico B, Frigeri A, Nicchia GP, et al. Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J. Cell Sci. 2001;114:1297
  46. Oopik M, Puksa L, Luus SM, Kaasik AE, Jakobsen J. Clinical and laboratory-reconfirmed myasthenia gravis: a population-based study. Eur. J. Neurol. 2008;15:246–252
  47. Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Eur. J. Physiol. 2008;456:693–700
  48. Phillips LH. The epidemiology of myasthenia gravis. Semin. Neurol. 2004;24:17–20
  49. Pittock S, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch. Neurol. 2008;65:629–632
  50. Pittock SJ, Lennon VA, De Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 2008;65:78–83
  51. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern specific loss of aquaporin-4 immunoreactivity distinguish neuromyelitis optical from multiple sclerosis. Brain. 2007;130(5):1194–1205
  52. Saadoun S, Papadopoulos MC, Davis DC, Krishna S, Bell BA. Aquaporin-4 expression is increased in oedematous human brain tumours. J. Neurol. Neurosurg. Psychiatry. 2002;72:262–265
  53. Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S, et al. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J. Neuroimmunol. 2009;215:31–35
  54. Silberstein C, Bouley R, Huang Y, Fang P, Pastor-Soler N, Brown D, et al. Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells. Am. J. Physiol. Renal Physiol. 2004;287:F501–F511
  55. Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S. Absence of aquaporin 4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 2007;113:187–194
  56. Strand L, Moe SE, Solbu TT, Vaadal M, Holen T. Roles of aquaporin-4 isoforms and amino acids in square array assembly. Biochemistry. 2009;48:5785–5793
  57. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235–1243
  58. Uzawa A, Mori M, Iwai Y, Kobayashi M, Hayakawa S, et al. Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J. Neurol. Sci. 2009;287(1–2):105–107
  59. Verkman AS. Mammalian aquaporins: diverse physiological roles and potential significance. Expert Rev. Mol. Med. 2008;10:1–18
  60. Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins — new players on cancer biology. J. Mol. Med. 2008;86:523–529
  61. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet. 2001;68:2122–2128
  62. Vincent T, Saikali P, Cayrol R, Roth AD, Bar-Or A, Prat A, et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J. Immunol. 2008;181:5730–5737
  63. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294–305
  64. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53:1107–1114
  65. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–815
  66. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 2001;49:146–154

PII: S0165-5728(10)00329-2

doi: 10.1016/j.jneuroim.2010.07.016

Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 178-184 , 8 October 2010

Article Tools

* Image Usage & Resolution